A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
This study is currently recruiting participants.
The purpose of this study is to evaluate how tolerable, safe, and effective it is to give INO-8875 eye drops to adults with glaucoma or ocular hypertension.
Ages Eligible for Study: 18 Years to 75 Years
Genders Eligible for Study: Both
Dr. Paul Sidoti, Glaucoma Specialist
Katy Tai, Research Manager
email@example.com or 212-979-4251